(Q84868722)
Statements
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program (English)
Sheena K Aurora
Paul Winner
Marshall C Freeman
Egilius L Spierings
Jessica O Heiring
Ronald E DeGryse
Amanda M VanDenburgh
Marissa E Nolan
Catherine C Turkel